International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7847835
Original Article
‘Family Centered Structured Play Therapy’: A Way To Combat Physical & Developmental Delay In Severe Acute Malnutrition
 ,
 ,
Published
April 20, 2023
Abstract
Introduction-The WHO recommends incorporating psycho-motor and psycho-social stimulation into the management of SAM as it helps recover the psycho-motor and psycho-social deficit and stimulate the malnourished children to regain their appetite more quickly and gain weight faster. Objectives-To determine the effect of Play based Psycho-Motor and Psycho-Social stimulation on development and linear growth in children with SAM and to estimate the prevalence of delayed developmental milestones in SAM. Methods- This prospective study included 130 SAM children of 6 months to 5 years age, play-based psychomotor and psycho-social stimulation was provided. Linear growth and developmental growth were assessed during hospital stay and at 3 months, 6 months follow up and outcome was assessed. Results- Among 130 SAM children, 601.5% were of age group 13-36 months, 60% were male and 40% female, majority belongs to upper lower socioeconomic class (80%). In 8.1% pedal edema present. 91.54% have delayed milestones in at least 1 domain, delayed social personal domain noted in maximum children (66.92%), mean weight was 6.19+/-1.44 kg and mean height 73.3+/-8.4cm at admission. During 6 months follow up maximum improvement noted in fine motor in 76.19% children followed by gross motor in 61.62% children. Mean weight gain after 6months was 2.05+/-0.17 kg and mean height gain was 2.52cm+/-0.14cm. Conclusion- developmental delay is associated with SAM (91.5%) in atleast one domain. Structured play therapy has positive effect on developmental growth and linear growth of SAM children.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1665 Views
37 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved